Cartesian Therapeutics Stock Based Compensation (TTM) Insights

Cartesian Therapeutics, Inc. (RNAC)

8.535 -0.12 (-1.33%) USD | NASDAQ | May 11, 16:00

8.535 0.00 (0.00%) After-Hours: 17:29

View Stock Based Compensation (TTM) for RNAC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Stock Based Compensation (TTM) Chart

Start Trial

View Historical Data

Start Trial

View Stock Based Compensation (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Stock Based Compensation (TTM) Benchmarks

Start Trial

Insmed, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Precision BioSciences, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade